SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-120251
Filing Date
2020-11-02
Accepted
2020-11-02 07:28:51
Documents
16
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2034736-1_8k.htm   iXBRL 8-K 33157
2 EXHIBIT 99.1 tm2034736d1_ex99-1.htm EX-99.1 196651
3 EXHIBIT 99.2 tm2034736d1_ex99-2.htm EX-99.2 23137
7 GRAPHIC tm2034736d1_ex99-1img01.jpg GRAPHIC 19181
8 GRAPHIC tm2034736d1_ex99-2img01.jpg GRAPHIC 17820
  Complete submission text file 0001104659-20-120251.txt   511585

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20201029.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20201029_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20201029_pre.xml EX-101.PRE 22708
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2034736-1_8k_htm.xml XML 3627
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 201278981
SIC: 2834 Pharmaceutical Preparations